The Gut Microbiota-Brain Axis in Acute Neurological Disease: Focus on Stroke.

IF 1.4 Q4 PHARMACOLOGY & PHARMACY Reviews on recent clinical trials Pub Date : 2022-01-01 DOI:10.2174/1574887117666220321155508
Angela Saviano, Gunawardena Gayani, Christian Zanza, Yaroslava Longhitano, Alessio Migneco, Marcello Candelli, Francesco Franceschi, Veronica Ojetti
{"title":"The Gut Microbiota-Brain Axis in Acute Neurological Disease: Focus on Stroke.","authors":"Angela Saviano,&nbsp;Gunawardena Gayani,&nbsp;Christian Zanza,&nbsp;Yaroslava Longhitano,&nbsp;Alessio Migneco,&nbsp;Marcello Candelli,&nbsp;Francesco Franceschi,&nbsp;Veronica Ojetti","doi":"10.2174/1574887117666220321155508","DOIUrl":null,"url":null,"abstract":"<p><p>The gut microbiota is one of the great innovations of modern medicine. In the modern microbiota revolution era, more comprehensive and in-depth studies have been performed regarding the microbial gut communities and their impact on acute and chronic diseases, including those of the nervous system as acute neurological diseases. The microbiota has changed our knowledge of medical conditions; in particular, considering stroke (both ischemic and hemorrhagic), literature studies, experimental and clinical researches indicate that the individual's risk and outcomes are substantially impacted by the gut microbiota. The aim of our review article is to investigate and discuss the recent insights into the emerging role of this complex \"gut microbiota-brain axis\" in affecting some acute neurological diseases, such as stroke, responsible for a significant number of deaths worldwide. We performed electronic research on PubMed® and collected articles published in the last ten years, finding that changes in the gut microbiota composition could affect various aspects of stroke pathophysiology and individual predisposition, risk, and outcomes. Our review article suggests that there is a strong connection between the gut microbiota and the brain, both in health and in acute neurological diseases such as stroke. Investigating and exploring this relationship can be a challenge useful to learn more about this disabling/deadly condition, and it can be a useful tool to identify novel potential therapeutic approaches, improving an individual's outcomes and life.</p>","PeriodicalId":21174,"journal":{"name":"Reviews on recent clinical trials","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews on recent clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574887117666220321155508","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 2

Abstract

The gut microbiota is one of the great innovations of modern medicine. In the modern microbiota revolution era, more comprehensive and in-depth studies have been performed regarding the microbial gut communities and their impact on acute and chronic diseases, including those of the nervous system as acute neurological diseases. The microbiota has changed our knowledge of medical conditions; in particular, considering stroke (both ischemic and hemorrhagic), literature studies, experimental and clinical researches indicate that the individual's risk and outcomes are substantially impacted by the gut microbiota. The aim of our review article is to investigate and discuss the recent insights into the emerging role of this complex "gut microbiota-brain axis" in affecting some acute neurological diseases, such as stroke, responsible for a significant number of deaths worldwide. We performed electronic research on PubMed® and collected articles published in the last ten years, finding that changes in the gut microbiota composition could affect various aspects of stroke pathophysiology and individual predisposition, risk, and outcomes. Our review article suggests that there is a strong connection between the gut microbiota and the brain, both in health and in acute neurological diseases such as stroke. Investigating and exploring this relationship can be a challenge useful to learn more about this disabling/deadly condition, and it can be a useful tool to identify novel potential therapeutic approaches, improving an individual's outcomes and life.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
急性神经系统疾病中的肠道微生物群-脑轴:以中风为重点。
肠道菌群是现代医学的伟大创新之一。在现代微生物群革命时代,人们对肠道微生物群落及其对急慢性疾病的影响进行了更全面和深入的研究,包括神经系统的急性神经系统疾病。微生物群改变了我们对医疗状况的认识;特别是,考虑到中风(缺血性和出血性),文献研究、实验和临床研究表明,个体的风险和结果在很大程度上受到肠道微生物群的影响。我们的综述文章的目的是调查和讨论最近对这种复杂的“肠道微生物群-脑轴”在影响一些急性神经系统疾病(如中风)中的新作用的见解,中风在全球范围内造成大量死亡。我们对PubMed®进行了电子研究,并收集了过去十年发表的文章,发现肠道微生物群组成的变化可能影响中风病理生理和个体易感性、风险和结果的各个方面。我们的综述文章表明,肠道微生物群和大脑之间存在着密切的联系,无论是在健康方面还是在中风等急性神经系统疾病中。调查和探索这种关系可以是一个挑战,有助于了解更多关于这种致残/致命的疾病,它可以是一个有用的工具,以确定新的潜在治疗方法,改善个人的结果和生活。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Reviews on recent clinical trials
Reviews on recent clinical trials PHARMACOLOGY & PHARMACY-
CiteScore
3.10
自引率
5.30%
发文量
44
期刊介绍: Reviews on Recent Clinical Trials publishes frontier reviews on recent clinical trials of major importance. The journal"s aim is to publish the highest quality review articles in the field. Topics covered include: important Phase I – IV clinical trial studies, clinical investigations at all stages of development and therapeutics. The journal is essential reading for all researchers and clinicians involved in drug therapy and clinical trials.
期刊最新文献
Impact of Upright Position during the First Stage of Labour on Maternal Outcomes: A Randomized Controlled Trial. Study on Rapid, Quantitative, and Simultaneous Detection of Drug Residues and Immunoassay in Chickens. Impact of a Symbiotic Mixture on Moderate-to-severe Diverticular Disease of the Colon. Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report. Is There an Association between 5a Reductase Inhibitors and Metabolic Syndrome? A Narrative Review of the Literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1